Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ProChon and MorphoSys identify new class of antibody

July 25, 2001

Methotrexate-albumin conjugate may be particularly useful against prostate cancer, sarcomas

July 25, 2001

QLT and Novartis Ophthalmics expand verteporfin codevelopment agreement

July 25, 2001

FDA advisory committee to review IntraDose

July 25, 2001

Cell Matrix awarded grants for development of novel antiangiogenesis products

July 25, 2001

Patient enrollment completed in SafeScience phase II pancreatic cancer trial

July 24, 2001

VEGF inhibitors useful for angiogenesis-related disorders according to Yamanouchi

July 24, 2001

Vion's Triapine enters phase II for treatment of leukemia

July 24, 2001

Patient enrollment completed in phase I trial of Inex's INX-3280

July 24, 2001

FDA Oncologic Drugs Advisory Committee to review Zevalin at upcoming meeting

July 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...